These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 18574751
1. Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD. Sukisaki T, Senjyu H, Oishi K, Rikitomi N, Ariyoshi K. Physiother Theory Pract; 2008; 24(4):255-63. PubMed ID: 18574751 [Abstract] [Full Text] [Related]
2. Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease. Satake M, Takahashi H, Sugawara K, Kawagoshi A, Tamaki A, Homma M, Morita R, Sato K, Sano M, Shioya T. Arzneimittelforschung; 2011; 61(1):8-13. PubMed ID: 21355441 [Abstract] [Full Text] [Related]
3. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD. Corda L, Bertella E, La Piana GE, Boni E, Redolfi S, Tantucci C. Respiration; 2008; 76(1):61-8. PubMed ID: 18319586 [Abstract] [Full Text] [Related]
4. Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients. Fogarty C, Hattersley H, Di Scala L, Drollmann A. Respir Med; 2011 Mar; 105(3):337-42. PubMed ID: 21144724 [Abstract] [Full Text] [Related]
5. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living. Shioya T, Satake M, Sato K, Sano MA, Sugawara K, Takahashi H, Honma M. Arzneimittelforschung; 2008 Mar; 58(1):24-8. PubMed ID: 18368947 [Abstract] [Full Text] [Related]
6. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD. Guenette JA, Raghavan N, Harris-McAllister V, Preston ME, Webb KA, O'Donnell DE. Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440 [Abstract] [Full Text] [Related]
7. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D. Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054 [Abstract] [Full Text] [Related]
8. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. Porto EF, Castro AA, Nascimento O, Oliveira RC, Cardoso F, Jardim JR. Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646 [Abstract] [Full Text] [Related]
10. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, Kramer B, INABLE 1 study group. Respir Med; 2011 Jul; 105(7):1030-6. PubMed ID: 21498063 [Abstract] [Full Text] [Related]
11. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme. den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C. Eur J Gen Pract; 2007 Jul; 13(2):89-91. PubMed ID: 17534745 [Abstract] [Full Text] [Related]
12. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD. Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659 [Abstract] [Full Text] [Related]
13. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE. Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181 [Abstract] [Full Text] [Related]
14. Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking. Sandland CJ, Morgan MD, Singh SJ. Respir Med; 2008 Aug; 102(8):1148-52. PubMed ID: 18571914 [Abstract] [Full Text] [Related]
15. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease. Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF. J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106 [Abstract] [Full Text] [Related]
16. Walking exercise response to bronchodilation in mild COPD: a randomized trial. Gagnon P, Saey D, Provencher S, Milot J, Bourbeau J, Tan WC, Martel S, Maltais F. Respir Med; 2012 Dec; 106(12):1695-705. PubMed ID: 22999808 [Abstract] [Full Text] [Related]
17. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Lee JH, Lee YK, Kim EK, Kim TH, Huh JW, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Kim N, Seo JB, Oh YM, Lee SD. Respir Med; 2010 Apr; 104(4):542-9. PubMed ID: 19926461 [Abstract] [Full Text] [Related]
18. Minimum clinically important improvement for the incremental shuttle walking test. Singh SJ, Jones PW, Evans R, Morgan MD. Thorax; 2008 Sep; 63(9):775-7. PubMed ID: 18390634 [Abstract] [Full Text] [Related]
19. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P. Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434 [Abstract] [Full Text] [Related]
20. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD. Cukier A, Ferreira CA, Stelmach R, Ribeiro M, Cortopassi F, Calverley PM. Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]